A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
AbbVie
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)